ArticleScientific reports2025
Effect of omega-3 fatty acids on adipose tissue: histological, metabolic, and gene expression analyses in mice fed a high-fat diet.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adipose Tissue Expandability as a Link Between Nutrition and Obesity-Related Metabolic Risk: Insights from Bariatric Surgery.Nutrients · 2026Review
- Decoding Adipose Tissue Phenotypic Switching: From Mechanisms to Computational Drug Discovery.Current obesity reports · 2026Review
- DHA ModulatesInternational journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Obesity is a metabolic disorder characterized by excessive fat accumulation due to energy imbalance. This study aimed to evaluate the effects of omega-3 fatty acids (n-3 FAs) on body weight, biochemical parameters, thermogenic gene expression, and adipose tissue morphology in a male C57BL/6 mice model of high-fat diet (HFD)-induced obesity initiated at 4 weeks of age. After a one-week adaptation, mice were randomly divided into four groups: a control group fed a standard diet (CD) and three experimental groups fed a HFD alone or enriched with 1.2% or 2.4% n-3 FAs. All groups were fed ad libitum for 12 weeks. Feed intake and body weight were recorded, and glucose and insulin tolerance tests were performed. Serum glucose, lipid profiles, insulin, leptin, and adiponectin levels were analyzed. Gene expression of uncoupling protein 1 (Ucp1), peroxisome proliferator-activated receptor gamma coactivator-1 alpha (Pgc-1α), PR domain containing 16 (Prdm16), and G protein-coupled receptor 120 (Gpr120) was evaluated in brown adipose tissue (BAT), along with histological assessments of both BAT and white adipose tissue (WAT). n-3 FAs improved serum lipid profiles and glucose metabolism without significant changes in body weight or energy intake. Although no significant differences were observed in the expression of Ucp1, Pgc-1α, and Gpr120, Prdm16 expression was significantly higher in the 1.2% HFD group (p < 0.05). Histological analysis showed that n-3 FAs prevented BAT whitening, promoted WAT browning, and reduced inflammatory infiltration. Ucp1 immunoreactivity was significantly lower in the HFD group compared to the CD group (p < 0.05). These findings suggest that n-3 FAs exerts multifaceted protective effects on adipose tissue at genetic, biochemical, and histological levels, highlighting their potential in the management of diet-induced obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.